This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Navidea Biopharmaceuticals Inc (NAVB)

AMEX: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 7.17M 5.48M 32.94M 9.12M
Receivables 3.70M 816.54K 1.15M 17.61K
Inventories 652.91K 932.38K 2.23M 297.50K
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 12.58M 8.60M 37.33M 10.62M
Property, Plant & Equipment, Gross 3.87M 4.12M 3.61M 2.03M
Accumulated Depreciation & Depletion 1.94M 1.61M 1.48M 1.09M
Property, Plant & Equipment, Net 1.93M 2.51M 2.13M 934.58K
Intangibles 186.16K 180.83K 136.85K 92.48K
Other Non-Current Assets 273.57K 630.49K 723.10K 327.95K
Total Non-Current Assets 2.39M 3.32M 2.99M 1.36M
Liabilities & Shareholder Equity
Total Assets 14.96M 11.92M 40.32M 11.97M
Accounts Payable 1.77M 1.48M 2.42M 1.42M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 6.18M 9.10M 11.29M 6.19M
Long Term Debt 60.75M 29.54M 23.57M 6.93M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 1.87M 3.09M 9.46M 257.12K
Minority Interest -855.00 0.00 0.00 0.00
Total Non-Current Liabilities 63.09M 32.63M 33.04M 7.19M
Total Liabilities 69.27M 41.72M 44.33M 13.38M
Preferred Stock Equity 0.00 4.00 8.00 7.00
Common Stock Equity -54.31M -29.80M -4.01M -1.41M
Common Par 155.65K 150.20K 135.92K 113.02K
Additional Paid In Capital 326.09M 323.03M 313.11M 273.04M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -380.55M -352.98M -317.26M -274.56M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 6.44M -264.33K 19.56M 5.52M
Total Equity -54.31M -29.80M -4.01M -1.41M
Total Liabilities & Stock Equity 14.96M 11.92M 40.32M 11.97M
Total Common Shares Outstanding 155.65M 150.20M 135.92M 113.02M
Preferred Shares 0.00 4.52K 7.57K 6.94K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 151.18M 148.75M 121.81M 99.06M
Diluted Weighted Shares Outstanding 151.18M 148.75M 121.81M 99.06M
Number of Employees 51 46 57 47
Number of Part-Time Employees 6 8 8 9
NAVB News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NAVB Navidea Biopharmaceuticals Inc

Chart of NAVB

Analysts Ratings for NAVB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 1 1 1 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NAVB ANALYST REPORT

NAVB Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs